AU4341189A - The receptor binding region of ebvgp350 - Google Patents

The receptor binding region of ebvgp350

Info

Publication number
AU4341189A
AU4341189A AU43411/89A AU4341189A AU4341189A AU 4341189 A AU4341189 A AU 4341189A AU 43411/89 A AU43411/89 A AU 43411/89A AU 4341189 A AU4341189 A AU 4341189A AU 4341189 A AU4341189 A AU 4341189A
Authority
AU
Australia
Prior art keywords
ebvgp350
receptor binding
binding region
receptor
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43411/89A
Other languages
English (en)
Inventor
Neil R. Cooper
Glen R. Nemerow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of AU4341189A publication Critical patent/AU4341189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU43411/89A 1988-10-03 1989-09-28 The receptor binding region of ebvgp350 Abandoned AU4341189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25320588A 1988-10-03 1988-10-03
US253205 1988-10-03

Publications (1)

Publication Number Publication Date
AU4341189A true AU4341189A (en) 1990-05-01

Family

ID=22959318

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43411/89A Abandoned AU4341189A (en) 1988-10-03 1989-09-28 The receptor binding region of ebvgp350

Country Status (5)

Country Link
EP (1) EP0436626A1 (fr)
AU (1) AU4341189A (fr)
GR (1) GR890100631A (fr)
PT (1) PT91877A (fr)
WO (1) WO1990004176A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
EP0536319B1 (fr) * 1990-06-29 1998-01-07 E.I. Du Pont De Nemours And Company Analyse permettant de detecter et/ou de determiner quantitativement une reponse d'anticorps mammaliens a un antigene de la membrane du virus d'epstein-barr
DK0788513T3 (da) * 1994-10-25 2001-04-02 Glaxo Group Ltd Anvendelse af bindingsmidler for CD23 i behandlingen af atoimmune sygdomme
ZA972087B (en) * 1996-03-15 1997-10-24 Theratech Inc Targeting macromolecular produgs to T lymphocytes.
US6432679B1 (en) 1998-06-12 2002-08-13 Henry M. Jackson Foundation For The Advancement Of Military Medicine Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220
EP1229043A1 (fr) * 2001-01-30 2002-08-07 Cyto-Barr B.V. Peptides derivees des proteines LMP1, LMP2 et BARF1 du virus Epstein Barr
FR2850384A1 (fr) * 2003-01-28 2004-07-30 Centre Nat Rech Scient Antigenes mimant les domaines extracellulaires de proteines membranaires de type iii issues de microorganismes intracellulaires pathogenes, anticorps conformationnels derives, et leurs applications
US20120108492A1 (en) * 2008-09-19 2012-05-03 The Regents Of The University Of Colorado Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
JP2015516376A (ja) * 2012-03-19 2015-06-11 ドイチェス クレブスフォルシュンクスツェントルム Ｔ細胞エピトープを含む、ｂ細胞受容体複合体結合タンパク質

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707358A (en) * 1984-01-30 1987-11-17 The University Of Chicago Vaccine against Epstein-Barr Virus
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.

Also Published As

Publication number Publication date
WO1990004176A1 (fr) 1990-04-19
GR890100631A (el) 1990-11-29
EP0436626A1 (fr) 1991-07-17
PT91877A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
AU3151689A (en) Improved cryo-slammer
AU3715993A (en) N-isopropylheteroaryloxyacetanilides
AU3949089A (en) Periodontium-regenerative materials
AU632763B2 (en) Substituted 9h-purines
AU3588189A (en) Polypeptide compounds
AU2864489A (en) 16-dehydro-vitamin d3-derivatives
AU3091089A (en) Substituted sulphonylaminoazoles
AU3642589A (en) 1-aryl-2-naphthoylamines
AU3163389A (en) 5-amino-1-phenylpyrazoles
AU4341189A (en) The receptor binding region of ebvgp350
AU3334389A (en) Rutheniumcomplex-compounds
AU3234289A (en) Co-dispenser
AU618619B2 (en) Novel combination
AU4628489A (en) Assayomate
AU612915B2 (en) Thermosetting-resin-forming composition
AU4471189A (en) Substituted oxadiaminobutanes
AU3300089A (en) Triazoloazines
AU3491189A (en) Substituted dibenzothiaphenes
AU3869789A (en) Pyrazolo-pyrrolo-pyrimidine-diones
AU3315089A (en) 2-substituted-2-cyclopentenones
AU3508989A (en) Des-17-histidine-calcitonin
AU4679689A (en) Polyhydroxybenzylpxypropanolamines
AU2508688A (en) Yacht-hull
AU3851189A (en) Recombinomas
AU3324689A (en) Substituted triazolylmethylcarbinols